LAVA Therapeutics (LVTX)
(Delayed Data from NSDQ)
$1.53 USD
+0.03 (1.66%)
Updated Aug 6, 2025 04:00 PM ET
After-Market: $1.52 -0.01 (-0.65%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth B Momentum D VGM
Fundamental Charts
About Market Cap
As of the previous market close, LAVA Therapeutics N.V. has a market cap of $39.59M, which represents its share price of $1.51 multiplied by its outstanding shares number of 26.31M. As a small-cap company, LVTX's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
LVTX 1.53 +0.03(1.66%)
Will LVTX be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for LVTX based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for LVTX
I'm Staying Neutral On XOMA Royalty After The LAVA And HilleVax Deals
LVTX: HC Wainwright & Co. Lowers Price Target, Maintains Neutral Rating | LVTX Stock News
This Block Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday
LAVA Therapeutics (LVTX) Downgraded by Jefferies with Lower Price Target | LVTX Stock News
LVTX Downgraded by Jefferies Following Acquisition News